Vehicle (placebo)
Sponsors
Zalicus, Bausch & Lomb Incorporated, Medicis Global Service Corporation, Botanix Pharmaceuticals, Pfizer
Conditions
Atopic DermatitisAtopic Dermatitis (AD)Bacterial ConjunctivitisCorneal Endothelial DystrophyCorneal Epithelial DefectDiabetic Foot Ulcer (DFU)Dystrophic Epidermolysis BullosaEndothelial Dysfunction
Phase 1
A Phase 1/ Phase 2 Study of TTHX1114(NM141)
CompletedNCT04520321
Start: 2020-08-19End: 2021-05-18Updated: 2023-10-30
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug
NCT05234320
Start: 2022-10-31End: 2023-01-31Target: 16Updated: 2022-09-22
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
Not yet recruitingNCT06678399
Start: 2025-04-01End: 2027-01-01Target: 91Updated: 2024-11-07
Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial
CompletedNCT06812637
Start: 2024-04-06End: 2024-09-02Updated: 2025-04-29
Phase 2
Study of CRx-191 to Assess Activity in Plaque Psoriasis
CompletedNCT00557739
Start: 2007-11-30End: 2008-01-31Target: 20Updated: 2008-09-25
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
CompletedNCT00972777
Start: 2009-10-31End: 2011-02-28Updated: 2012-03-29
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
CompletedNCT01703793
Start: 2012-09-30End: 2013-01-31Updated: 2013-01-09
A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
CompletedNCT03024255
Start: 2016-12-22End: 2017-09-19Updated: 2023-05-16
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
CompletedNCT03850483
Start: 2019-04-08End: 2021-04-20Updated: 2022-06-29
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
CompletedNCT03903822
Start: 2019-05-13End: 2020-05-07Updated: 2021-03-29
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
CompletedNCT06058000
Start: 2023-11-13End: 2024-09-30Updated: 2025-03-12
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
RecruitingNCT06594393
Start: 2026-01-30End: 2027-06-30Target: 32Updated: 2026-01-29
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
CompletedNCT06810050
Start: 2024-12-18End: 2025-10-30Updated: 2026-04-02
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Not yet recruitingNCT07005180
Start: 2026-02-28End: 2027-03-31Target: 36Updated: 2026-01-08
To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis
CompletedNCT07120308
Start: 2021-09-15End: 2023-01-30Updated: 2025-08-13